D
PTC Therapeutics, Inc. PTCT
$50.57 $1.653.37% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 178.88M 1.18B 213.17M 196.79M 186.70M
Total Other Revenue -- -- -- -- --
Total Revenue 178.88M 1.18B 213.17M 196.79M 186.70M
Cost of Revenue 124.41M 121.84M 141.05M 172.26M 147.70M
Gross Profit 54.47M 1.05B 72.12M 24.53M 39.01M
SG&A Expenses 85.26M 80.96M 84.68M 73.46M 69.50M
Depreciation & Amortization 4.06M 3.80M 3.31M 3.04M 2.87M
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 213.73M 206.59M 229.04M 248.75M 220.06M
Operating Income -34.86M 969.50M -15.87M -51.97M -33.36M
Income Before Tax -71.05M 929.83M -94.70M -97.99M -85.73M
Income Tax Expenses -6.20M 63.27M -28.81M 8.66M 13.45M
Earnings from Continuing Operations -64.85M 866.56M -65.89M -106.65M -99.18M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -64.85M 866.56M -65.89M -106.65M -99.18M
EBIT -34.86M 969.50M -15.87M -51.97M -33.36M
EBITDA -27.28M 976.72M -9.11M -45.48M -26.34M
EPS Basic -0.83 11.09 -0.85 -1.39 -1.29
Normalized Basic EPS -0.57 7.45 0.36 -0.82 -0.61
EPS Diluted -0.83 10.04 -0.85 -1.39 -1.29
Normalized Diluted EPS -0.57 6.74 0.36 -0.82 -0.61
Average Basic Shares Outstanding 78.15M 78.12M 77.20M 76.93M 76.73M
Average Diluted Shares Outstanding 78.15M 86.39M 77.20M 76.93M 76.73M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --